Tom 12, Nr 3 (2018)
Wybrane problemy kliniczne
Opublikowany online: 2018-07-13
Wyświetlenia strony
4230
Wyświetlenia/pobrania artykułu
16717
HPV-pozytywny rak jamy ustnej - etiologia i czynniki ryzyka.
Forum Medycyny Rodzinnej 2018;12(3):102-106.
Streszczenie
Zakażenie wirusem HPV w jamie ustnej jest jednym z czynników etiologicznych rozwoju raka płaskonabłonkowego jamy ustnej (OSCC) oraz gardła środkowego. HPV (+) OSCC związany z obecnością zakażenia wirusem HPV w jamie ustnej wydaje się wiązać z lepszym rokowaniem i odpowiedzią na leczenie niż rak, którego głównymi czynnikami etiologicznymi są alkohol czy tytoń. Dlatego też bardzo istotna jest kwalifikacja pacjenta do odpowiedniej grupy. Celem tej pracy jest przedstawienie czynników ryzyka infekcji wirusem HPV oraz implikacji, jakie niesie ze sobą zakażenie. Wiedza ta ułatwi lekarzom zwiększanie świadomości pacjentów.
Słowa kluczowe: HPVOSCCrak płaskonabłonkowy jamy ustnej
Referencje
- Whelan SL, Ferlay J. Cancer Incidence in Five Continents. Age-specific and standardized incidence rates. IARC Sci Publ. 1992(120): 178–861.
- Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000; 92(9): 709–720.
- Herrero R, Castellsagué X, Franceschi S. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003; 95(23): 1772–1783.
- D’Souza G, Agrawal Y, Halpern J, et al. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009; 199(1): 1263–1269.
- Gillison ML, Broutian T, Pickard RKL, et al. Prevalence of oral HPV infection in the United States, 2009–2010. JAMA. 2012; 307(7): 693–703.
- D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356(19): 1944–1956.
- Hariri S, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007; 297(8): 813–819.
- Baig S, Siddiqui A, Nayeem A, et al. Human papilloma virus--role in precancerous and cancerous oral lesions of tobacco chewers. J Pak Med Assoc. 2013; 63(10): 1295–1298.
- Dürst M, Gissmann L, Ikenberg H, et al. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A. 1983; 80(12): 3812–3815.
- Zur Hausen H. The search for infectious causes of human cancers: where and why. Virology. 2009; 392(1): 1–10.
- Nichols AC, Faquin WC, Westra WH, et al. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2009; 140(2): 228–234.
- Syrjänen S. Human papillomavirus infections and oral tumors. Med Microbiol Immunol. 2003; 192(3): 123–128.
- Goon PKC, Stanley MA, Ebmeyer J, et al. HPV & head and neck cancer: a descriptive update. Head Neck Oncol. 2009; 1: 36.
- Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005; 14(2): 467–475.
- Schwartz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst. 1998; 90(21): 1626–1636.
- Kreimer AR, Villa A, Nyitray AG, et al. The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev. 2011; 20(1): 172–182.
- Bosch FX, Lorincz A, Muñoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55(4): 244–265.
- van Houten VM, Snijders PJ, van den Brekel MW, et al. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer. 2001; 93(2): 232–235.
- Ragin CC, Reshmi SC, Gollin SM. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Int J Cancer. 2004; 110(5): 701–709.
- Tsoumpou I, Arbyn M, Kyrgiou M, et al. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev. 2009; 35(3): 210–220.
- Klozar J, Kratochvil V, Salakova M, et al. HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol. 2008; 265(Suppl 1): S75–S82.
- Mellin H, Friesland S, Lewensohn R, et al. Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survival. Int J Cancer. 2000; 89(3): 300–304, doi: 10.1002/1097-0215(20000520)89:3<300::aid-ijc14>3.0.co;2-g.
- Iyer NG, Dogan S, Palmer F, et al. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer. Ann Surg Oncol. 2015; 22(13): 4411–4421.
- Dahlgren L, Dahlstrand HM, Lindquist D, et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer. 2004; 112(6): 1015–1019.
- Näsman A, Nordfors C, Holzhauser S, et al. Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: a stabilisation of an epidemic of viral induced carcinoma? Eur J Cancer. 2015; 51(1): 55–61.
- D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356(19): 1944–1956.
- Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008; 100(6): 407–420.
